<?xml version="1.0" encoding="UTF-8"?>
<p>The antiparasitic agent ivermectin may be another therapeutic approach worth exploring further. In an in vitro study, it showed a 99.98% reduction in viral load after 48 h of treatment, in three samples [
 <xref rid="B112-jcm-09-01917" ref-type="bibr">112</xref>]. The drug is not toxic at a standard dose, and is safe for pregnant women, which makes it a strong candidate for evaluation in clinical trials [
 <xref rid="B112-jcm-09-01917" ref-type="bibr">112</xref>].
</p>
